Prediction driven design of hERG liability free compounds - webcast
Posted by
Ákos Tarcsay
on 2021-09-13
The new ChemAxon ADMET plugin group builds on the power of machine learning methods on curated data sets to support the drug design and medicinal chemistry optimization with reliable models and predictions. The first available pre-trained model is targeting the elimination of cardiotoxicity risk during drug discovery by predicting hERG inhibition.
In the presentation below, we demonstrate the model development and assessment data on our hERG pAct regression model. We also discuss the requirements of modern applications interfacing with machine learning models that lead to higher detail prediction results, such as estimated error, applicability domain, and the visualization of similar training compounds.
Related content
16 07 2024
< 1 minute
New Feature Release: Reaction Enumeration in Design Hub
New Feature Release: Reaction Enumeration in Design Hub
25 04 2024
< 1 minute
Pharma use case with Design Hub: Digital workflow support for compound design
Design Hub case study - use case with a renowned German pharmaceutical company.
05 07 2023
< 1 minute
Overcome challenges in collaborating with CROs - Documentation
Optimize CRO collaboration and documentation challenges with Design Hub's streamlined solutions for...
21 06 2023
< 1 minute
Overcome challenges in collaborating with CROs - Communication
Streamline communication and accelerate collaboration with CROs using Chemaxon's Design Hub. Learn...